APA (7th ed.) Citation

W, S., J, Y., L, W., Y, Z., Z, Y., Y, C., . . . W, L. (2026). A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer. European journal of clinical pharmacology, 82(4), . https://doi.org/10.1007/s00228-026-04013-x

Chicago Style (17th ed.) Citation

W, Shao, Yang J, Wu L, Zhou Y, Yu Z, Cheng Y, Cai Q, and Liu W. "A Systematic Review and Meta-analysis of Exposure-response Analysis of Osimertinib in Patients with Non-small-cell Lung Cancer." European Journal of Clinical Pharmacology 82, no. 4 (2026). https://doi.org/10.1007/s00228-026-04013-x.

MLA (9th ed.) Citation

W, Shao, et al. "A Systematic Review and Meta-analysis of Exposure-response Analysis of Osimertinib in Patients with Non-small-cell Lung Cancer." European Journal of Clinical Pharmacology, vol. 82, no. 4, 2026, https://doi.org/10.1007/s00228-026-04013-x.